EXPERT PERSPECTIVES
A New Foundation for Designing Winning Brand Strategies – The Patient Journey Re-envisioned
The years immediately preceding a pharmaceutical product launch are arguably one of the riskiest periods in business and “getting it right” has never been more essential. IMS experts discuss the importance of the patient journey – a powerful framework for understanding the market and patient experience – in driving brand growth.
LATEST THINKING
Achieving Launch Excellence in Oncology: Four key drivers marketers need to consider for oncology launch planning.
Balancing Act – Aligning Competing Strategies: How to harmonize efforts across new commercial model and launch excellence initiatives.
IMS Asia-Pacific Insight: The heated price-volume debate mounts in Asia.
Our insights are your competitive advantage.
IMS Consulting Group is the world’s leading, specialized advisor on critical business issues in life sciences.
With a global presence and local expertise across five continents, we know the pulse of the market – anticipating change, understanding its impact and resolving the challenges it brings. From pricing and market access and marketing issues to product, portfolio and geographic investment decisions – our life sciences consulting teams offer insights that drive results. All backed by the strongest evidence and analytics.
Brand & Commercial Strategy
Pharma growth rates will be the lowest ever through 2014. What questions should you address?
Geographic Investments
By 2014, pharmerging markets will drive 50% of global growth. How can you harness their potential?
Health Economics & Outcomes Research
Real-world evidence is transforming the landscape. Are you capturing the outcomes that count?
Launch Excellence
Less than 1% of launches outperform. What does it take to be the best?
Strategy & Portfolio Analysis
Only 20% of medicines recoup the costs of development. How can you maximize return?


